Second, the fact that PTH levels were not measured precluded the ability to determine whether or not the relationship between 25(OH)D3 and clinical measures of adiposity was caused by secondary hyperparathyroidism. The gene discussed is PTH; the disease is secondary hyperparathyroidism.